Ratings by RBC Capital (Luca Issi)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/6/2023 | Graphite Bio Inc | GRPH | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/18/2022 | Editas Medicine | EDIT | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/11/2022 | WAVE Life Sciences | WVE | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/11/2022 | Homology Medicines | FIXX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/11/2022 | Adverum Biotechnologies | ADVM | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/8/2022 | Verve Therapeutics | VERV | Maintain | Outperform (N/A) |
|
Details | ||
| 11/7/2022 | bluebird bio | BLUE | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/7/2022 | Beam Therapeutics Inc | BEAM | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/4/2022 | Regenxbio Inc. | RGNX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/4/2022 | Intellia Therapeutics | NTLA | Maintain | Outperform (N/A) |
|
Details | ||
| 11/3/2022 | Editas Medicine | EDIT | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/2/2022 | CRISPR Therapeutics | CRSP | Maintain | Sector Perform (N/A) |
|
Details | ||
| 10/4/2022 | Regenxbio Inc. | RGNX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 9/20/2022 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 8/12/2022 | Adverum Biotechnologies | ADVM | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/5/2022 | bluebird bio | BLUE | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/4/2022 | Intellia Therapeutics | NTLA | Maintain | Outperform (N/A) |
|
Details | ||
| 8/4/2022 | Regenxbio Inc. | RGNX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 5/13/2022 | Caribou Biosciences Inc. | CRBU | Maintain | Outperform (N/A) |
|
Details | ||
| 5/10/2022 | CRISPR Therapeutics | CRSP | Maintain | Sector Perform (N/A) |
|
Details | ||
| 5/3/2022 | Sangamo BioSciences | SGMO | Maintain | Outperform (N/A) |
|
Details | ||
| 5/3/2022 | Sangamo BioSciences | SGMO | Maintain | Outperform (N/A) |
|
Details | ||
| 2/22/2022 | Homology Medicines | FIXX | Downgrade | Sector Perform (Outperform) |
3.86 (1.70) |
-55.96% | Details | |
| 2/18/2022 | Graphite Bio Inc | GRPH | New Coverage | Sector Perform (N/A) |
11.02 (2.12) |
-80.76% | Details | |
| 2/18/2022 | Caribou Biosciences Inc. | CRBU | New Coverage | Outperform (N/A) |
11.37 (7.36) |
-35.27% | Details | |
| 2/18/2022 | Verve Therapeutics | VERV | New Coverage | Outperform (N/A) |
30.21 (22.56) |
-25.32% | Details | |
| 2/16/2022 | CRISPR Therapeutics | CRSP | Maintain | Sector Perform (N/A) |
|
Details | ||
| 12/14/2021 | Allogene | ALLO | Maintain | Outperform (N/A) |
|
Details | ||
| 12/8/2021 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 11/22/2021 | Alnylam Pharmaceuticals | ALNY | Upgrade | Outperform (Sector Perform) |
178.98 (233.03) |
30.2% | Details | |
| 11/19/2021 | Dicerna Pharmaceuticals | DRNA | Downgrade | Sector Perform (Outperform) |
21.28 (38.22) |
79.61% | Details | |
| 11/8/2021 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 11/8/2021 | bluebird bio | BLUE | Maintain | Sector Perform (N/A) |
|
Details | ||
| 10/11/2021 | Regenxbio Inc. | RGNX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 10/8/2021 | Allogene | ALLO | Maintain | Outperform (N/A) |
|
Details | ||
| 10/7/2021 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 9/14/2021 | Regenxbio Inc. | RGNX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/10/2021 | bluebird bio | BLUE | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/6/2021 | Dicerna Pharmaceuticals | DRNA | Maintain | Outperform (N/A) |
|
Details | ||
| 7/2/2021 | Arrowhead Pharma | ARWR | Maintain | Outperform (N/A) |
|
Details | ||
| 6/29/2021 | Intellia Therapeutics | NTLA | Maintain | Outperform (N/A) |
|
Details | ||
| 5/4/2021 | Intellia Therapeutics | NTLA | New Coverage | Outperform (N/A) |
76.77 (43.67) |
-43.12% | Details | |
| 5/4/2021 | Beam Inc | BEAM | New Coverage | Sector Perform (N/A) |
82.00 (48.11) |
-41.33% | Details | |
| 5/4/2021 | Editas Medicine | EDIT | New Coverage | Sector Perform (N/A) |
37.01 (11.17) |
-69.82% | Details | |
| 5/4/2021 | Sangamo BioSciences | SGMO | New Coverage | Outperform (N/A) |
11.78 (3.54) |
-69.95% | Details | |
| 4/29/2021 | Adverum Biotechnologies | ADVM | Downgrade | Sector Perform (Outperform) |
10.16 (0.69) |
-93.21% | Details | |
| 4/20/2021 | CRISPR Therapeutics | CRSP | Maintain | Sector Perform (N/A) |
|
Details | ||
| 3/30/2021 | WAVE Life Sciences | WVE | Maintain | Sector Perform (N/A) |
|
Details | ||
| 3/29/2021 | bluebird bio | BLUE | Maintain | Sector Perform (N/A) |
|
Details | ||
| 3/23/2021 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 3/23/2021 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 2/25/2021 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 1/28/2021 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 1/20/2021 | Regenxbio Inc. | RGNX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/24/2020 | Arrowhead Pharma | ARWR | Maintain | Outperform (N/A) |
|
Details | ||
| 10/23/2020 | uniQure BV | QURE | New Coverage | Outperform (N/A) |
39.50 (22.46) |
-43.14% | Details | |
| 10/23/2020 | Allogene | ALLO | Maintain | Outperform (N/A) |
|
Details | ||
| 9/1/2020 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 6/16/2020 | Adverum Biotechnologies | ADVM | Maintain | Outperform (N/A) |
|
Details | ||
| 5/13/2020 | Regenxbio Inc. | RGNX | New Coverage | Sector Perform (N/A) |
41.38 (23.28) |
-43.74% | Details | |
| 5/13/2020 | Homology Medicines | FIXX | New Coverage | Outperform (N/A) |
13.49 (1.70) |
-87.4% | Details | |
| 5/13/2020 | Dicerna Pharmaceuticals | DRNA | New Coverage | Outperform (N/A) |
24.35 (38.22) |
56.96% | Details | |
| 5/13/2020 | Adverum Biotechnologies | ADVM | New Coverage | Outperform (N/A) |
19.80 (10.16) |
-48.69% | Details | |
| 5/13/2020 | bluebird bio | BLUE | New Coverage | Outperform (N/A) |
60.23 (6.64) |
-88.98% | Details | |
| 5/13/2020 | Arrowhead Research | ARWR | New Coverage | Outperform (N/A) |
36.30 (33.37) |
-8.07% | Details | |
| 5/13/2020 | Ionis Pharmaceuticals | IONS | New Coverage | Outperform (N/A) |
56.18 (40.74) |
-27.48% | Details | |
| 5/13/2020 | Alnylam Pharmaceuticals | ALNY | New Coverage | Sector Perform (N/A) |
142.43 (233.03) |
63.61% | Details | |
| 10/23/0003 | CRISPR Therapeutics | CRSP | New Coverage | Sector Perform (N/A) |
92.22 (55.80) |
-39.49% | Details | |
| 10/23/0003 | WAVE Life Sciences | WVE | New Coverage | Sector Perform (N/A) |
8.21 (5.09) |
-38% | Details |
